Interleukin-6, tissue factor and von Willebrand factor in acute decompensated heart failure : relationship to treatment and prognosis
Is recurrent venous thromboembolism more frequent in homozygous patients for the factor V Leiden mutation than in heterozygous patients?
Protein C and protein S assessment in hospital laboratories : which strategy and what role for DNA sequencing?
Overexpression of glycosyl phosphatidylinositol-anchored tissue factor pathway inhibitor-1 inhibits tissue factor activity
Comparison of six D-dimer methods in patients suspected of deep vein thrombosis
Thrombin activatable fibrinolysis inhibitor and hemostatic changes in patients with type I diabetes mellitus with and without microvascular complications
Enhancement of fibrinolytic potential in vitro by anticoagulant drugs targeting activated factor X, but not by those inhibiting thrombin or tissue factor
Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes : evidence from recent clinical trials
Associations of haemostatic variables with body mass index : a community-based study
Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced thrombomodulin downregulation
Efficacy of pentasaccharide on a prethrombosis model based on a calibrated stasis by the increase in up-stream venous pressure
On the correlation between local fibrinolytic activity in menstrual fluid and total blood loss during menstruation and effects of desmopressin
Unsuspected mesenteric vein thrombosis in a patient with a hereditary bleeding disorder
Management of lepirudin therapy for a patient with antiphospholipid antibody syndrome using the whole blood ecarin clot time and activated partial thromboplastin time